Literature DB >> 29408544

Pyroptosis: An inflammatory link between NAFLD and NASH with potential therapeutic implications.

Juliane I Beier1, Jesus M Banales2.   

Abstract

Entities:  

Keywords:  GSDMD; Gasdermin D; Hepatocellular death

Mesh：

Substances：

Year:  2018        PMID： 29408544      PMCID： PMC6185810          DOI： 10.1016/j.jhep.2018.01.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  20 in total

Review 1.  Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells.

Authors:  Susan L Fink; Brad T Cookson
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 2.  Apoptosis: a review of programmed cell death.

Authors:  Susan Elmore
Journal:  Toxicol Pathol       Date:  2007-06       Impact factor: 1.902

Review 3.  The global NAFLD epidemic.

Authors:  Rohit Loomba; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

4.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

Authors: 
Journal:  J Hepatol       Date:  2016-04-07       Impact factor: 25.083

Review 5.  Programmed cell death as a defence against infection.

Authors:  Ine Jorgensen; Manira Rayamajhi; Edward A Miao
Journal:  Nat Rev Immunol       Date:  2017-01-31       Impact factor: 53.106

6.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.

Authors:  Jianjin Shi; Yue Zhao; Kun Wang; Xuyan Shi; Yue Wang; Huanwei Huang; Yinghua Zhuang; Tao Cai; Fengchao Wang; Feng Shao
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

7.  PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.

Authors:  Marcin Krawczyk; Raúl Jiménez-Agüero; José M Alustiza; José I Emparanza; María J Perugorria; Luis Bujanda; Frank Lammert; Jesús M Banales
Journal:  Surg Obes Relat Dis       Date:  2016-07-01       Impact factor: 4.734

Review 8.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

9.  Autophagy regulates lipid metabolism.

Authors:  Rajat Singh; Susmita Kaushik; Yongjun Wang; Youqing Xiang; Inna Novak; Masaaki Komatsu; Keiji Tanaka; Ana Maria Cuervo; Mark J Czaja
Journal:  Nature       Date:  2009-04-01       Impact factor: 49.962

10.  Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease.

Authors:  Rocío Gallego-Durán; Pablo Cerro-Salido; Emilio Gomez-Gonzalez; María Jesús Pareja; Javier Ampuero; María Carmen Rico; Rafael Aznar; Eduardo Vilar-Gomez; Elisabetta Bugianesi; Javier Crespo; Francisco José González-Sánchez; Reyes Aparcero; Inmaculada Moreno; Susana Soto; María Teresa Arias-Loste; Javier Abad; Isidora Ranchal; Raúl Jesús Andrade; Jose Luis Calleja; Miguel Pastrana; Oreste Lo Iacono; Manuel Romero-Gómez
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379
View more
  18 in total

Review 1.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 2.  Hepatic Stellate Cell-Immune Interactions in NASH.

Authors:  James K Carter; Scott L Friedman
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 3.  Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.

Authors:  Jianan Zhao; Yiyang Hu; Jinghua Peng
Journal:  Cell Mol Biol Lett       Date:  2021-05-07       Impact factor: 5.787

Review 4.  The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease.

Authors:  Sanjoy Roychowdhury; Praveen Conjeevaram Selvakumar; Gail A M Cresci
Journal:  Med Sci (Basel)       Date:  2018-06-05

Review 5.  Pyroptosis in Liver Disease: New Insights into Disease Mechanisms.

Authors:  Jiali Wu; Su Lin; Bo Wan; Bharat Velani; Yueyong Zhu
Journal:  Aging Dis       Date:  2019-10-01       Impact factor: 6.745

Review 6.  Cell Death in Liver Diseases: A Review.

Authors:  Layla Shojaie; Andrea Iorga; Lily Dara
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

7.  Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.

Authors:  Kangkang Yin; Xiao Zhou; Wei Jiang; Linlin Wang; Ziwei Dai; Biao Tang
Journal:  Dis Markers       Date:  2021-06-18       Impact factor: 3.434

Review 8.  Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe?

Authors:  Jiajia Chen; Xiaoyi Deng; Yongjian Liu; Qiuhua Tan; Guidong Huang; Qishi Che; Jiao Guo; Zhengquan Su
Journal:  Int J Biol Sci       Date:  2020-06-23       Impact factor: 6.580

Review 9.  Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development.

Authors:  Simona-Rebeca Ignat; Sorina Dinescu; Anca Hermenean; Marieta Costache
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

10.  Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis.

Authors:  Weijian Mai; Yangzhi Xu; Jiahui Xu; Dan Zhao; Liangying Ye; Ganxiang Yu; Zhilei Wang; Qianting Lu; Jiaen Lin; Tao Yang; Chengxin Gu; Shiming Liu; Yun Zhong; Hui Yang
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.